Dovepress open access nanojournals joining our project SHARE YOUR NANOSCIENCE
Check back time to time!
International Journal of Nanomedicine (ISSN: 1178-2013)
An international, peer-reviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Reflecting the growing activity in this emerging specialty, the aim of this journal is to highlight research and development leading to potential clinical applications in the prevention and treatment of disease.
Endorsed by the American Society for Nanomedicine. Journal Impact Factor: 3.463 (5 year impact 4.027)
Nanotechnology, Science and Applications (ISSN: 1177-8903)
Nanotechnology, Science and Applications is an international, peer-reviewed, Open Access journal that focuses on the science of nanotechnology in a wide range of industrial and academic applications.
The journal is characterized by the rapid reporting of reviews, original research, and application studies across all sectors, including engineering, optics, bio-medicine, cosmetics, textiles, resource sustainability and science. Applied research into nano-materials, particles, nano-structures and fabrication, diagnostics and analytics, drug delivery and toxicology constitute the primary direction of the journal.
Nanobiosensors in Disease Diagnosis (Newly launched journal) (ISSN 2230-6153)
Nanobiosensors in Disease Diagnosis is an international, peer-reviewed, open access journal publishing original research, reports, reviews and commentaries including but not confined to:
• Diagnosis of diseases including cancer, cardiovascular, infectious diseases
• Molecular modeling in diagnosis
• Enzyme and membrane technologies
• Quantum dot fluorescence technologies for monitoring toxins and pathogens
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine. Dove Medical Press was founded in 2003 with the objective of combining the highest editorial standards with the 'best of breed' new publishing technologies. We have offices in Manchester and London in the United Kingdom, Memphis, Tennessee in the United States, and our editorial offices are in Auckland, New Zealand.